tm
Seeing Is Believing
tm
Seeing Is Believing
GALT is currently covered by 1 analysts with an average price target of $11. This is a potential upside of $7.68 (231.33%) from yesterday's end of day stock price of $3.32.
Galectin Therapeutics's activity chart (see below) currently has 25 price targets and 29 ratings on display. The stock rating distribution of GALT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 45.14% with an average time for these price targets to be met of 191.5 days.
Highest price target for GALT is $11, Lowest price target is $11, average price target is $11.
Most recent stock forecast was given by MATTHEW KELLER from HC WAINWRIGHT on 23-Jun-2026. First documented stock forecast 29-Sep-2016.
Currently out of the existing stock ratings of GALT, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Aug-2025
$11
$7.68 (231.33%)
$11
4 months 9 days ago
(23-Jun-2026)
1/3 (33.33%)
$7.88 (252.56%)
81
Hold Since 02-Apr-2025
1 years 6 months 30 days ago
(02-Apr-2025)
3/12 (25%)
$8.23 (297.11%)
213
Buy Since 13-Feb-2019
$4
$0.68 (20.48%)
$8
6 years 6 months 29 days ago
(03-Apr-2020)
1/3 (33.33%)
$2.28 (132.56%)
388
Buy Since 19-Oct-2017
$8
$4.68 (140.96%)
$10
8 years 9 months 28 days ago
(04-Jan-2018)
2/3 (66.67%)
$3.74 (87.79%)
200
Buy Since 06-Oct-2017
$5
$1.68 (50.60%)
$2
9 years 26 days ago
(06-Oct-2017)
3/3 (100%)
$2.56 (104.92%)
99
What is GALT (Galectin Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GALT (Galectin Therapeutics)?
Which analyst has the current lower performing score on GALT (Galectin Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GALT (Galectin Therapeutics)?
Which analyst is the currently most bullish on GALT (Galectin Therapeutics)?
Which analyst is the currently most reserved on GALT (Galectin Therapeutics)?
